Jointly sponsored by ACCP and the American Society of Health-System Pharmacists
Session Overview
The BCOP Clinical Sessions are one component of the professional development program developed by ACCP and the American Society of Health-System Pharmacists (ASHP) and approved for the recertification by the Board of Pharmacy Specialties (BPS) for the recertification of Board Certified Oncology Pharmacists (BCOPs). Successful completion of a web-based posttest will be required to earn recertification credit for the clinical sessions, live or home study.
Program Content
The 2017 BCOP Clinical Sessions are offered in two parts. The first part is focused on Bayesian Statistics and will provide an overview of how to compare, interpret, and evaluate Bayesian statistics. The second part of the BCOP Clinical Sessions will examine the new drug updates and the management of nausea and vomiting.
Faculty
|
Robert Beckett, Pharm.D.
Associate Professor of Pharmacy Practice
Director of the Drug Information Center
Manchester University
Fort Wayne, Indiana |
|
Joseph K. Jordan, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Drug Information Specialist - IU Health
Butler University
Indianapolis, Indiana |
|
Amanda N. Seddon, Pharm.D., BCPS, BCOP
Clinical Pharmacy Specialist, Hematology/Oncology/Cellular Therapy
Rush University Medical Center
Chicago, Illinois |
|
Mary Golf, Pharm.D.
Pharmacy Manager, Hematology/Oncology
PGY2 Oncology Residency Program Director, Department of Pharmacy
Northwestern Memorial Hospital
Chicago, Illinois |
Target Audience and Program Goals
Clinical Pharmacists and BCOPs providing care to patients with cancer.
At the conclusion of the program, the participant should be able to:
Lung Cancer Therapy and Molecular Targets
- Compare and contrast Bayesian and frequentist statistics and how they can be used in oncology-related clincal studies.
- Interpret Bayesian statistics information in the methods and results of an oncology-related clinical study, including adaptive designs.
- Evaluate Bayesian statistics information in the methods and results of an oncology-related clinical study, including adaptive designs.
Updates on New Drugs and the Management of Nausea and Vomiting
- Evaluate the clinical benefit of olaratumab in soft tissue sarcomas.
- Examine the relationship between BRCA mutations and PARP inhibitors and distinguish the therapeutic role of PARP inhibition in ovarian cancer.
- Examine the role of CDK 3/4 inhibition in breast cancer and the clinical benefit of ribociclib.
- Recommend a monitoring plan and dose adjustment to manage ribociclib toxicities.
- Compare the mechanism of action of PD-1 and PD-L1 inhibitors.
- Assess the clinical benefit and place in therapy for durvalumab and avelumab.
- Discuss the prognostic significance of FLT3 mutated AML and explain the clinical benefit seen with midostaurin in the RATIFY trial.
- Summarize the key elements of chemotherapy-induced nausea and vomiting.
- Assess the current, published guidelines for chemotherapy-induced nausea and vomiting.
- Identify and recommend therapeutic options for the management of chemotherapy-induced nausea and vomiting.
Continuing Pharmacy Education Credit
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Both BCOP Clinical Sessions are application-based activities.
BCOP Clinical Sessions – An Oncology Pharmacist's Guide to Bayesian Statistics;
Activity Number: 0217-9999-17-161-H04-P; 2.0 contact hours.
BCOP Clinical Sessions – Updates on New Drugs and the Management of Nausea and Vomiting;
Activity Number: 0217-9999-17-162-H01-P; 2.0 contact hours.
To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by October 1, 2019. Partial credit is not available for each activity.
BCOP Specialty Recertification Credit
To be eligible for 4.0 CPE hours of recertification credit, BCOPs must listen to all 4.0 contact hours of the recorded presentations and then successfully complete a Web-based posttest by March 31, 2018. Partial credit is available for this activity.
ACCP, as the official provider approved by BPS, will record and report recertification credit earned for this activity directly to BPS.
Technical Requirements
Requires an Internet browser and Adobe Reader.
Fees
ASHP members, please call (913) 492-3311 to receive the member discount.
Description |
Price |
Nonmember |
Cart |
Specialty Recertification Program with 4.0 Continuing Education Credits
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed under Continuing Pharmacy Education Credit above.
Test submission deadline for recertification is March 31, 2018. |
$150.00 |
$210.00 |
|
Online Program with 4.0 Continuing Education Credits (CPE only)
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed under Continuing Pharmacy Education Credit above.
This product does not include specialty recertification credit. Test submission deadline for CPE credit is October 1, 2019. |
$100.00 |
$160.00 |
|
Financial Support
No financial support from external supporters was obtained for this course.